{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:38:20Z","timestamp":1791819500528,"version":"4.3.4"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T00:00:00Z","timestamp":1461196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["NHRI-EX103- 10334EI"],"award-info":[{"award-number":["NHRI-EX103- 10334EI"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0153573","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T18:11:29Z","timestamp":1461262289000},"page":"e0153573","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Solvent\/Detergent Virally Inactivated Serum Eye Drops Restore Healthy Ocular Epithelium in a Rabbit Model of Dry-Eye Syndrome"],"prefix":"10.1371","volume":"11","author":[{"given":"Ching-Li","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yi","family":"Renn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Hung","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Burnouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0002-9394(14)71688-5","article-title":"Prevalence of dry eye among the elderly","volume":"124","author":"OD Schein","year":"1997","journal-title":"American Journal of Ophthalmology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/978-1-4615-0717-8_38","article-title":"Epidemiology of dry eye syndrome","volume":"506","author":"DA Schaumberg","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/bjo.83.4.390","article-title":"Treatment of dry eye by autologous serum application in Sjogren's syndrome","volume":"83","author":"K Tsubota","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.bmt.1703862","article-title":"Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease","volume":"31","author":"Y Ogawa","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/bjo.2004.044347","article-title":"Autologous serum eye drops for ocular surface disorders","volume":"88","author":"G Geerling","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/bjo.2003.026211","article-title":"Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease","volume":"88","author":"BA Noble","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00417-014-2599-1","article-title":"The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study","volume":"252","author":"AR Celebi","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1537-2995.2008.01665.x","article-title":"Autologous serum eyedrops: literature review and implications for transfusion medicine specialists","volume":"48","author":"C Yamada","year":"2008","journal-title":"Transfusion"},{"key":"ref9","article-title":"Quality, safety and sustained therapeutic efficacy of blood-derived serum eye drops to treat dry eye syndrome: R&D road map for future progress","author":"J Segatchian","journal-title":"Transfus Apher Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.transci.2015.05.013","article-title":"A concise overview of advances in therapeutic efficacy of serum eye drops and their alternatives to treat dry eye syndrome: Verifying the narratives of clinical consistency beyond the periphery of international inconsistency on the methods of collection and application","volume":"53","author":"J Seghatchian","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2013.11.001","article-title":"Single-reagent one-step procedures for the purification of ovine IgG, F (ab\u2032) 2 and Fab antivenoms by caprylic acid","volume":"402","author":"I Al-Abdulla","year":"2014","journal-title":"Journal of immunological methods"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1755-3768.1992.tb02169.x","article-title":"Epidermal growth factor (EGF) in ocular fluids: presence, origin and therapeutical considerations","author":"GB van Setten","year":"1992","journal-title":"Acta Ophthalmol Suppl"},{"issue":"Suppl 1","key":"ref13","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/ICO.0b013e31817f3a0e","article-title":"Autologous serum eye drops for the treatment of dry eye diseases","volume":"27","author":"T Kojima","year":"2008","journal-title":"Cornea"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.transci.2015.05.015","article-title":"Serum eye drop preparation in Australia: Current manufacturing practice","volume":"53","author":"DC Marks","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"ref15","article-title":"Sustained benefits of autologous serum eye drops on self-reported ocular symptoms and vision-related quality of life in australian patients with dry eye and corneal epithelial defects","author":"P Mondy","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/ICO.0b013e3180645cd7","article-title":"Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease","volume":"26","author":"CC Chiang","year":"2007","journal-title":"Cornea"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.eye.6703079","article-title":"Allogeneic serum eye drops for the treatment of persistent corneal epithelial defect","volume":"23","author":"CC Chiang","year":"2009","journal-title":"Eye (Lond)"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/jop.2012.0002","article-title":"Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease","volume":"28","author":"KS Na","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/aos.12386","article-title":"Ready-made allogeneic ABO-specific serum eye drops: production from regular male blood donors, clinical routine, safety and efficacy","volume":"92","author":"LH Harritshoj","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.transci.2015.05.014","article-title":"Implementation of a standardised method for the production of allogeneic serum eye drops from regular blood donors in a Norwegian University Hospital: Some methodological aspects and clinical considerations","volume":"53","author":"A Espinosa","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1054\/blre.2000.0129","article-title":"Reducing the risk of infection from plasma products: specific preventative strategies","volume":"14","author":"T Burnouf","year":"2000","journal-title":"Blood Rev"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/bjh.12031","article-title":"Emerging pathogens and their implications for the blood supply and transfusion transmitted infections","volume":"159","author":"RY Dodd","year":"2012","journal-title":"Br J Haematol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tracli.2009.04.004","article-title":"Protecting the blood supply from emerging pathogens: the role of pathogen inactivation","volume":"16","author":"MA Blajchman","year":"2009","journal-title":"Transfus Clin Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1423-0410.2012.01662.x","article-title":"Component pathogen inactivation: a critical review","volume":"104","author":"CV Prowse","year":"2013","journal-title":"Vox Sang"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1537-2995.2008.01691.x","article-title":"Solvent\/detergent treatment of platelet concentrates enhances the release of growth factors","volume":"48","author":"T Burnouf","year":"2008","journal-title":"Transfusion"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1423-0410.2009.01180.x","article-title":"A virally inactivated functional growth factor preparation from human platelet concentrates","volume":"97","author":"CY Su","year":"2009","journal-title":"Vox Sang"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1111\/j.1537-2995.2008.01862.x","article-title":"Quantitative assessment of the kinetics of growth factors release from platelet gel","volume":"48","author":"CY Su","year":"2008","journal-title":"Transfusion"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1167\/iovs.07-0720","article-title":"A rabbit dry eyemode induced by topical medication of a preservative benzalkonium chloride","volume":"49","author":"C Xiong","year":"2008","journal-title":"Investigative Ophthalmology & Visual Science (IVOS)"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e33688","DOI":"10.1371\/journal.pone.0033688","article-title":"Research on the stability of a rabbit dry eye model induced by topical application of the preservative benzalkonium chloride","volume":"7","author":"C Li","year":"2012","journal-title":"PLoS ONE"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.transci.2015.05.016","article-title":"Animal models to assess the therapeutic efficacy of human serum and serum-converted platelet lysates for dry eye syndrome: Seeing is believing","volume":"53","author":"CL Tseng","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: Report of the definition and classification (Subcommittee of the International Dry Eye Workshop)","volume":"5","author":"BC Lemp MA","year":"2007","journal-title":"The Ocular Surface"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1167\/iovs.02-0581","article-title":"Apoptosis of ocular surface cells in experimentally induced dry eye","volume":"44","author":"S Yeh","year":"2003","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/ICO.0b013e31821c9b5a","article-title":"Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye","volume":"30","author":"HS Lee","year":"2011","journal-title":"Cornea"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajo.2006.11.060","article-title":"Impact of dry eye syndrome on vision-related quality of life","volume":"143","author":"B Miljanovic","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1542-0124(12)70082-4","article-title":"The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000150445","article-title":"Inflammatory markers in the tears of patients with ocular surface disease","volume":"40","author":"A Acera","year":"2008","journal-title":"Ophthalmic Res"},{"key":"ref37","first-page":"533","article-title":"Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells","volume":"17","author":"ME Cavet","year":"2011","journal-title":"Molecular Vision"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/ICL.0000000000000104","article-title":"Autologous serum eye drops for the treatment of ocular surface disease","volume":"41","author":"AA Azari","year":"2015","journal-title":"Eye Contact Lens"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/ICU.0000000000000169","article-title":"Eye platelet-rich plasma in the treatment of ocular surface disorders","volume":"26","author":"JL Alio","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/ICO.0b013e318186321e","article-title":"Time- and temperature-dependent stability of growth factor peptides in human autologous serum eye drops","volume":"28","author":"JC Bradley","year":"2009","journal-title":"Cornea"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.transci.2015.05.017","article-title":"Autologous and allogeneic serum eye drops. The Dutch perspective","volume":"53","author":"PF van der Meer","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1537-2995.2010.02804.x","article-title":"Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms","volume":"51","author":"J Weusten","year":"2011","journal-title":"Transfusion"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/j.1537-2995.2009.02212.x","article-title":"Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions","volume":"49","author":"CM Nubling","year":"2009","journal-title":"Transfusion"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/voxs.12070","article-title":"Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections","volume":"9","author":"SL Stramer","year":"2014","journal-title":"ISBT Sci Ser"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JVI.01437-06","article-title":"Viral infection of the lungs through the eye","volume":"81","author":"V Bitko","year":"2007","journal-title":"Journal of Virology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/j.1537-2995.2009.02222.x","article-title":"Robustness of solvent\/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies","volume":"49","author":"HO Dichtelmuller","year":"2009","journal-title":"Transfusion"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-3148.2009.00963.x","article-title":"Solvent-detergent filtered (S\/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system","volume":"20","author":"M El-Ekiaby","year":"2010","journal-title":"Transfus Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e0117800","DOI":"10.1371\/journal.pone.0117800","article-title":"TnBPTriton X-45 treatment of plasma for transfusion efficiently inactivates hepatitis C virus","volume":"10","author":"ML Chou","year":"2015","journal-title":"PLoS One"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1423-0410.2012.01621.x","article-title":"Dengue virus inactivation by minipool TnBP\/Triton X-45 treatment of plasma and cryoprecipitate","volume":"104","author":"T Burnouf","year":"2013","journal-title":"Vox Sang"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1423-0410.2011.01560.x","article-title":"Impact of solvent\/detergent treatment of plasma on transfusion-relevant bacteria","volume":"102","author":"ML Chou","year":"2012","journal-title":"Vox Sang"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/02713680601147690","article-title":"Albumin rescues ocular epithelial cells from cell death in dry eye","volume":"32","author":"A Higuchi","year":"2007","journal-title":"Curr Eye Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/vox.12264","article-title":"Anti-inflammatory effects of platelet biomaterials in a macrophage cellular model","volume":"109","author":"TY Renn","year":"2015","journal-title":"Vox Sang"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ab.2009.03.016","article-title":"Comparative removal of solvent and detergent viral inactivating agents from human intravenous immunoglobulin G preparations using SDR HyperD and C18 sorbents","volume":"389","author":"T Burnouf","year":"2009","journal-title":"Anal Biochem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1537-2995.2010.02915.x","article-title":"Expansion of adipose tissue mesenchymal stromal progenitors in serum-free medium supplemented with virally inactivated allogeneic human platelet lysate","volume":"51","author":"DT Shih","year":"2011","journal-title":"Transfusion"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","article-title":"Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication","volume":"86","author":"PJ Pisella","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"ref56","first-page":"308","article-title":"Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas","volume":"19","author":"NL Burstein","year":"1980","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1167\/iovs.07-0720","article-title":"A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride","volume":"49","author":"C Xiong","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref58","first-page":"257","article-title":"A mouse dry eye model induced by topical administration of benzalkonium chloride","volume":"17","author":"Z Lin","year":"2011","journal-title":"Mol Vis"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1167\/iovs.03-1055","article-title":"Animal models of dry eye: a critical assessment of opportunities and limitations","volume":"45","author":"S Barabino","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0153573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T22:17:26Z","timestamp":1718489846000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0153573"}},"subtitle":[],"editor":[{"given":"Andrew W","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,21]]},"references-count":59,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0153573","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,21]]}}}